【原著論文】
Onishi R, Ikemoto S, Shiota A, Tsukamoto T, Asayama A, Tachibana M, Sakurai F, Mizuguchi H.
Development of a novel adenovirus serotype 35 vector vaccine possessing an RGD peptide in the fiber knob and the E4 orf 4, 6, and 6/7 regions of adenovirus serotype 5.
Int J Pharm. 2024:124480.

Xie Z, Kawai A, Watanabe N, Okada N, Yoshioka Y, Tachibana M. (corresponding author)
Adoptively Transferred Myeloid-Derived Suppressor Cells Decrease Influenza A Virus Infection Mortality in a Mouse Model
BPB Reports 2024;7(2):26-32.

Shao J, Ye Z, Shen Z, Liu N, Zhang L, Tachibana M, Xie Z.
Chidamide improves gefitinib treatment outcomes in NSCLC by attenuating recruitment and immunosuppressive function of myeloid-derived suppressor cells.
Biomed Pharmacother. 2024;173:116306.